Clinical Trial Update: Efficacy of Subcutaneous Infliximab in Acute Severe Ulcerative Colitis: a Multicenter Retrospective Study

View source ↗

Summary

A multicenter retrospective study assesses the efficacy of subcutaneous infliximab in acute severe ulcerative colitis. The trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Ulcerative Colitis | Status: NOT_YET_RECRUITING